FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to a novel derivative of 5'-O-(4-chlorophenoxyacetyl)-N4-hydroxycytidine, as well as to a method for production thereof and use of the compound for inhibiting replication of SARS-CoV-2 coronavirus.
EFFECT: novel compound having high activity against coronavirus SARS-CoV-2 is obtained.
6 cl, 3 ex, 3 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| 5'-O-(4-PHENYLBUTANOYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 | 
 | RU2817201C1 | 
| METHOD FOR OBTAINING 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE | 2022 | 
 | RU2791916C1 | 
| 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE AND ITS APPLICATION | 2022 | 
 | RU2791523C1 | 
| USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 | 
 | RU2791806C1 | 
| URACIL DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 | 2021 | 
 | RU2769828C1 | 
| PHARMACEUTICAL COMPOSITION CONTAINING 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE | 2024 | 
 | RU2838512C1 | 
| mRNA-BASED VECTOR FOR INCREASED TARGET PROTEIN PRODUCTION IN MAMMALIAN CELLS (VARIANTS) | 2022 | 
 | RU2792231C1 | 
| OBTAINING A WATER-SOLUBLE 6-BROMO-1-METHYL-5-METHOXY-2-(1-PIPERIDINOMETHYL)-3-(2-DIETHYLAMINOETHOXY) CARBONYLINDOLE DIHYDROCHLORIDE COMPOUND | 2024 | 
 | RU2835077C1 | 
| MODIFIED ANTISENSE OLIGONUCLEOTIDE AGAINST SARS-CoV-2 | 2020 | 
 | RU2750584C1 | 
| APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 | 
 | RU2780247C1 | 
Authors
Dates
2024-04-16—Published
2023-10-18—Filed